Additional Chromosome Structural Aberrations Are Associated with Poorer Clinical Outcomes in Multiple Myeloma Patients with Hyperdiploidy

被引：0
|
作者：
Carballo-Zarate, Adrian
Medeiros, L. Jeffrey
Hao, Suyang
Orlowski, Robert
Lin, Pei
Lu Xinyan
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
[2] Houston Methodist Hosp, Houston, TX USA
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1341
引用
收藏
页码：338A / 338A
页数：1
相关论文
共 50 条
  • [1] Additional Chromosome Structural Aberrations Are Associated with Poorer Clinical Outcomes in Multiple Myeloma Patients with Hyperdiploidy
    Carballo-Zarate, Adrian
    Medeiros, L. Jeffrey
    Hao, Suyang
    Orlowski, Robert
    Lin, Pei
    Lu Xinyan
    LABORATORY INVESTIGATION, 2016, 96 : 338A - 338A
  • [2] Aberrations of chromosome X in patients with multiple myeloma
    Balcarkova, Jana
    Flodr, Patrik
    Svobodova, Nela
    Pika, Tomas
    Krhovska, Petra
    Papajik, Tomas
    Urbankova, Helena
    Minarik, Jiri
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E56 - E57
  • [3] Additional-structural-chromosomal aberrations are associated with inferior clinical outcome in patients with hyperdiploid multiple myeloma: a single-institution experience
    Carballo-Zarate, Adrian A.
    Medeiros, L. Jeffrey
    Fang, Lianghua
    Shah, Jatin J.
    Weber, Donna M.
    Thomas, Sheeba K.
    Manasanch, Elisabet E.
    Hao, Suyang
    Shen, Qi
    Orlowski, Robert Z.
    Lin, Pei
    Lu, Xinyan
    MODERN PATHOLOGY, 2017, 30 (06) : 843 - 853
  • [4] The Temporal Evolution of Chromosome 1q Gain and Hyperdiploidy and Its Impact on Clinical Outcomes in Multiple Myeloma
    Maura, Francesco
    Kaddoura, Marcella
    Poos, Alexandra Maria
    Cirrincione, Anthony
    Diamond, Benjamin
    Maclachlan, Kylee H.
    Ziccheddu, Bachisio
    Mai, Elias K.
    Goldschmidt, Hartmut
    Weisel, Katja
    Fenk, Roland
    Morgan, Gareth J.
    Usmani, Saad Z.
    Landgren, Ola
    Raab, Marc S.
    Weinhold, Niels
    BLOOD, 2023, 142
  • [5] Hyperdiploidy in multiple myeloma is associated with a distinct pattern of microRNA
    del Rio-Machin, Ana
    Ferreira, Bibiana
    Henry, Travis
    Gomez-Lopez, Gonzalo
    Agirre, Xabier
    Alvarez, Sara
    Rodriguez-Perales, Sandra
    Prosper, Felipe
    Jose Calasanz, M.
    Martinez, Joaquin
    Fonseca, Rafael
    Cigudosa, Juan C.
    CHROMOSOME RESEARCH, 2011, 19 : S31 - S32
  • [6] Prognostic significance of chromosome aberrations in multiple myeloma
    Zubasheva, Ye. I.
    Obukhova, T. N.
    Andreyeva, N. Ye.
    Vodinskaya, L. A.
    Alimova, G. A.
    Varlamova, Ye. Yu.
    Kulikov, S. M.
    Domracheva, Ye. V.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2008, 53 (06): : 31 - 36
  • [7] Impact of Additional Chromosome 1q Copies on Multiple Myeloma Survival Outcomes
    Thalambedu, Nishanth
    Sawyer, Jeffery
    Lukacs, Janet L.
    Farmer, Phil
    Al-Hadidi, Samer
    Schinke, Carolina
    Thanendrarajan, Sharmilan
    van Rhee, Frits
    Zangari, Maurizio
    BLOOD, 2024, 144 : 4726 - 4727
  • [8] Identification of specific transcriptional patterns associated with hyperdiploidy in multiple myeloma.
    Neri, Antonino
    Todoerti, Katia
    Agnelli, Luca
    Fabris, Sonia
    Bicciato, Silvio
    Mosca, Laura
    Nobili, Lucia
    Verdelli, Donata
    Ronchetti, Domenica
    Intini, Danicla
    Lionetti, Marta
    Deliliers, Giorgio Lambertenghi
    Lombardi, Luigia
    BLOOD, 2006, 108 (11) : 974A - 974A
  • [9] Fluorescence in situ hybridization analysis of chromosome aberrations in 60 Chinese patients with multiple myeloma
    Xiao Gao
    Chunming Li
    Run Zhang
    Ruifang Yang
    Xiaoyan Qu
    Hairong Qiu
    Jiaren Xu
    Hua Lu
    Jianyong Li
    Lijuan Chen
    Medical Oncology, 2012, 29 : 2200 - 2206
  • [10] Fluorescence in situ hybridization analysis of chromosome aberrations in 60 Chinese patients with multiple myeloma
    Gao, Xiao
    Li, Chunming
    Zhang, Run
    Yang, Ruifang
    Qu, Xiaoyan
    Qiu, Hairong
    Xu, Jiaren
    Lu, Hua
    Li, Jianyong
    Chen, Lijuan
    MEDICAL ONCOLOGY, 2012, 29 (03) : 2200 - 2206
12345